GlassScriptPhysician profile
Marc A Melser
NPI 1063480085
$7,865.20
in general payments reported to CMS, 2019-2025
31 companies · $2,783 in 2025
The $2,783 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $550 · 2020: $459 · 2021: $729 · 2022: $771 · 2023: $652 · 2024: $1,921 · 2025: $2,783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,672 · Food and Beverage: $2,620 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,671.56 |
| Food and Beverage | $2,619.89 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $3,616.41 | 2024-2025 | Aquabeam System |
| Endo Pharmaceuticals INC. | $869.49 | 2019-2024 | Aveed, Edex, Xiaflex |
| Janssen Biotech, INC. | $809.96 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $502.13 | 2019-2024 | Myrbetriq, Xtandi |
| Antares Pharma, INC. | $265.74 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Endo USA, INC. | $248.62 | 2024-2025 | Xiaflex, Aveed, Edex |
| Boston Scientific Corporation | $247.85 | 2019-2025 | Spaceoar Vue System - 10ml |
| Myriad Genetic Laboratories, INC. | $239.51 | 2021-2024 | Prolaris |
| Coloplast Corp | $116.80 | 2019-2024 | Self-Cath, Speedicath |
| Telix Pharmaceuticals | $109.23 | 2024-2025 | Illuccix |
| Sumitomo Pharma America, INC. | $108.80 | 2023-2025 | Orgovyx |
| Novartis Pharmaceuticals Corporation | $83.25 | 2023-2024 | |
| Travere Therapeutics, INC. | $72.36 | 2020-2021 | |
| Halozyme INC | $60.60 | 2023 | |
| Allergan, INC. | $54.62 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $52.19 | 2025 | |
| Dendreon Pharmaceuticals LLC | $49.60 | 2019-2022 | |
| Pfizer INC. | $44.85 | 2020-2021 | |
| Tolmar, INC. | $37.32 | 2023-2025 | Eligard |
| Acerus Pharmaceuticals Corporation | $36.87 | 2021 | |
| Blue Earth Diagnostics | $36.17 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $30.60 | 2023 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $27.32 | 2021-2022 | |
| 180 Medical, INC. | $24.19 | 2024 | |
| Teleflex LLC | $21.18 | 2022 | |
| Ferring Pharmaceuticals INC. | $19.64 | 2025 | Adstiladrin |
| Civco Medical Instruments | $18.05 | 2024 | |
| Urovant Sciences INC | $16.21 | 2021 | |
| Abbvie INC. | $15.88 | 2022 | |
| Urogen Pharma, INC. | $15.86 | 2025 | |
| Kerecis Limited | $13.90 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Melser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.